Jazz Pharmaceuticals announces private offering of 2032 exchangeable notes
Jazz Pharmaceuticals said it is offering $1.0 billion of exchangeable senior notes due 2032 via a private offering and will repurchase ordinary shares concurrently.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.